Status:
UNKNOWN
Effect of Acetaminophen Versus Ibuprofen in Treating Recurrent Apthous Ulcers in Pediatric Celiac Disease
Lead Sponsor:
Cairo University
Conditions:
Celiac Disease in Children
Eligibility:
All Genders
4-15 years
Phase:
PHASE4
Brief Summary
Celiac disease (CD) is a chronic autoimmune enteropathy. It results from genetic predisposition and exposure to gluten-containing food. Individuals carrying human leucocytes antigen (HLA) markers DQ2 ...
Detailed Description
Celiac disease is an immune-mediated systemic disease triggered by intake of gluten in genetically susceptible individuals. The prevalence of celiac disease in the general population is estimated to b...
Eligibility Criteria
Inclusion
- \- 1. Children with clinical diagnosis with a celiac disease.
- 2\. presence of recurrent apthous ulcers.
Exclusion
- 1\. History of allergy to any ingredient present in the drugs to be used for treatment.
- 2\. Children whose parents had no home or mobile phone to enable post-operative contact.
- 3\. Parent that who refuse to sign the informed consent.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06149507
Start Date
March 1 2024
End Date
December 1 2024
Last Update
December 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.